Welcome to CDC stacks | Lack of Effect of Lamivudine on Ebola Virus Replication - 28121 | Emerging Infectious Diseases
Stacks Logo
Advanced Search
Select up to three search categories and corresponding keywords using the fields to the right. Refer to the Help section for more detailed instructions.
 
 
Help
Clear All Simple Search
Advanced Search
Lack of Effect of Lamivudine on Ebola Virus Replication
Filetype[PDF-483.95 KB]


No Related Documents.
You May Also Like:
  1. Porcine Epidemic Diarrhea Virus Replication in Duck Intestinal Cell Line
    Personal Author:
    Khatri, Mahesh
    Published:
    Mar 2015
    Source:
    Emerg Infect Dis. 21(3):549-550.
    File Type:
    Filetype[PDF - 299.54 KB]
  2. Phenotypic and Genotypic Shifts in Hepatitis B Virus in Treatment-Naive Patients, Taiwan, 2008–2012
    Personal Author:
    Yeh, Chau-Ting; Liang, Kung-Hao; Chang, Ming-Ling; Hsu, Chao-Wei; Chen, Yi-Cheng; Lin, Chih-Lang; Lin, Wey-Ran; Lai, Ming-Wei;
    Published:
    May 2017
    Source:
    Emerg Infect Dis. 23(5):820-821.
    Description:
    We examined the characteristic changes of hepatitis B virus (HBV) in antiviral drug treatment-naive patients referred for pretreatment evaluation in Taiwan during 2008-2012. Over time, we observed substantial decreases in the prevalence of HBV e anti...
    File Type:
    Filetype[PDF - 1.00 MB]
  3. Correction: Vol. 21, No. 2
    Published:
    Mar 2015
    Source:
    Emerg Infect Dis. 21(3):552.
    File Type:
    Filetype[PDF - 329.18 KB]
  4. Report of the NIH Panel to Define Principles of Therapy of HIV Infection; and, Guidelines for the use of antiretroviral agents in HIV-infected adults and adolescents
    Personal Author:
    Feinberg, Mark B.; Kaplan, Jonathan E.; Stanley, Sharilyn K.;
    Corporate Author:
    Centers for Disease Control and Prevention (U.S.). Centers for Disease Control and Prevention (U.S.). Henry J. Kaiser Family Foundation. National Center for Infectious Diseases (U.S.), Division of AIDS, STD, and TB Laboratory Research.. National Center for HIV, STD, and TB Prevention (U.S.), Division of HIV/AIDS Prevention–Surveillance, and Epidemiology.. National Institute of Health (U.S.), Panel to Define Principles of Therapy of HIV Infection.. United States, Department of Health and Human Services., Panel on Clinical Practices for the Treatment of HIV Infection..
    Published:
    April 24, 1998
    Series:
    MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports; v. 47, no. RR-5
    Description:
    Report of the NIH Panel to Define Principles of Therapy of HIV Infection: Recent research advances have afforded substantially improved understanding of the biology of human immunodeficiency virus (HIV) infection and the pathogenesis of the acquired ...
    File Type:
    Filetype[PDF - 723.68 KB]
  5. Guidelines for the use of antiretroviral agents in HIV-infected adults and adolescents
    Personal Author:
    Stanley, Sharilyn K.; Kaplan, Jonathan E.;
    Corporate Author:
    United States. Department of Health and Human Services. Panel on Clinical Practices for the Treatment of HIV Infection.. National Institute of Allergy and Infectious Diseases (U.S.). Henry J. Kaiser Family Foundation.. National Center for Infectious Diseases (U.S.). Division of AIDS, STD, and TB Laboratory Research.. National Center for HIV, STD, and TB Prevention (U.S.). Division of HIV/AIDS Prevention–Surveillance, and Epidemiology..
    Published:
    April 24, 1998
    Source:
    MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports / Centers for Disease Control. 1998; 47(RR-5):43-82.
    Description:
    With the development and FDA approval of an increasing number of antiretroviral agents, decisions regarding the treatment of HIV-infected persons have become complex; and the field continues to evolve rapidly. In 1996, the Department of Health and Hu...
    File Type:
    Filetype[PDF - 723.68 KB]